FDA Brief

Company record

Park Avenue Compounding

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Park Avenue Compounding.

Recalls

ReportedClassFirmProduct and reason
Dec 10, 2025 Class II Park Avenue Compounding
Drug
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
CGMP Deviations
FDA notice D-0200-2026
Nov 26, 2025 Class II Park Avenue Compounding
Drug
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
FDA notice D-0178-2026